Cargando…

Editorial: Molecular genetics of cutaneous melanoma: current status and future direction-volume II

Detalles Bibliográficos
Autores principales:	Garcia-Casado, Zaida, Pellegrini, Cristina, Cho, William C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502205/ https://www.ncbi.nlm.nih.gov/pubmed/37719266 http://dx.doi.org/10.3389/fmolb.2023.1273849

Ejemplares similares

Editorial: Molecular Genetics of Cutaneous Melanoma: Current Status and Future Direction
por: Pellegrini, Cristina, et al.
Publicado: (2021)

Editorial: Ferroptosis in cancer and Beyond—volume II
por: Wang, Xin, et al.
Publicado: (2023)

Editorial: Structural dynamics of membrane proteins, Volume II
por: Raghuraman, H., et al.
Publicado: (2022)

Editorial: Systems modeling: Approaches and applications–Volume II
por: Garrido, Daniel, et al.
Publicado: (2022)

Editorial: Bioengineered nanoparticles in cancer therapy, Volume II
por: Zarrintaj, Payam, et al.
Publicado: (2022)

Editorial: Tumorigenesis regulated by miRNAs, Volume II
por: Liu, Taomei, et al.
Publicado: (2023)

Editorial: Weak interactions in molecular machinery volume II
por: Corrales-Guerrero, Laura, et al.
Publicado: (2023)

Editorial: Aromatic amino acid metabolism–Volume II
por: Li, Jianyong, et al.
Publicado: (2023)

Editorial: Volume II: Structural and functional characterization of circular RNAs
por: Sinha, Tanvi, et al.
Publicado: (2022)

Editorial: OMICS-based approaches in sports research volume II
por: Elrayess, Mohamed A., et al.
Publicado: (2022)

Editorial: Protein-Material interfaces: Fundamentals and applications volume II
por: Faccio, Greta, et al.
Publicado: (2023)

Editorial: Volume II: Tumor microenvironment in cancer hallmarks and therapeutics
por: Shi, Rongchen, et al.
Publicado: (2023)

Editorial: Interactions between proteins and biomacromolecules: Tools and applications (volume II)
por: Zhang, Fuming, et al.
Publicado: (2022)

Editorial: The role of calcium channels in human health and disease—Volume II
por: Zhang, Peng, et al.
Publicado: (2023)

Editorial: Web tools for modeling and analysis of biomolecular interactions Volume II
por: Andreani, Jessica, et al.
Publicado: (2023)

Editorial: Computational solutions for microbiome and metagenomics sequencing analyses, Volume II
por: Niyogisubizo, Jovial, et al.
Publicado: (2023)

Editorial: The upcoming complications of COVID-19 on recovered patients: molecular mechanisms and therapeutic opportunities, volume II
por: Seradj, Seyed Hassan, et al.
Publicado: (2023)

Editorial: NAD+ metabolism as a novel target against infection–Volume II
por: Balducci, Enrico, et al.
Publicado: (2022)

Editorial: Application of systems biology in molecular characterization and diagnosis of cancer, Volume II
por: Wei, Yongjun, et al.
Publicado: (2022)

Editorial: Cancer treatment and early detection targeting HER receptors, Volume II
por: Cai, Xiaoqing, et al.
Publicado: (2023)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms, Volume II
por: Jerez, Sofia, et al.
Publicado: (2023)

Editorial: AI and multi-omics for rare diseases: Challenges, advances and perspectives, Volume II
por: Bottini, Silvia, et al.
Publicado: (2022)

Editorial: ADAM, ADAMTS and astacin proteases: Challenges and breakthroughs in the -Omics era-Volume II
por: Kwok, Hang Fai, et al.
Publicado: (2023)

Editorial: Venom peptides: A rich combinatorial library for drug development, volume II
por: Servent, Denis, et al.
Publicado: (2023)

Editorial: Prokaryotic Communications, Volume II: From Macromolecular Interdomain to Intercellular Talks (Recognition) and Beyond
por: Yeo, Chew Chieng, et al.
Publicado: (2022)

Editorial: Transport of Nutrients, Metabolites and Ions linked to Bioenergetics: Relevance to Human Pathology, Volume II
por: Scalise, Mariafrancesca, et al.
Publicado: (2022)

The Integrative Analysis Identifies Three Cancer Subtypes and Stemness Features in Cutaneous Melanoma
por: Wang, Xiaoran, et al.
Publicado: (2021)

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
por: Wozniak, Michal, et al.
Publicado: (2023)

FAT10 is a Prognostic Biomarker and Correlated With Immune Infiltrates in Skin Cutaneous Melanoma
por: Wang, Yu, et al.
Publicado: (2022)

Current State of Target Treatment in BRAF Mutated Melanoma
por: Tanda, Enrica Teresa, et al.
Publicado: (2020)

m6A-Related lncRNAs Are Potential Biomarkers for the Prognosis of Metastatic Skin Cutaneous Melanoma
por: Huang, Suyang, et al.
Publicado: (2021)

The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
por: Vanni, Irene, et al.
Publicado: (2020)

Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma
por: Ying, Haoxuan, et al.
Publicado: (2021)

Editorial: Novel approaches aiming to overcome current nanomedicine limitations
por: Palomba, Roberto, et al.
Publicado: (2023)

Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling
por: Wang, Mona Meng, et al.
Publicado: (2021)

Identification of the m(6)A RNA Methylation Regulators WTAP as a Novel Prognostic Biomarker and Genomic Alterations in Cutaneous Melanoma
por: Feng, Zi-Yi, et al.
Publicado: (2021)

Structure Determination of Microtubules and Pili: Past, Present, and Future Directions
por: Garnett, James A., et al.
Publicado: (2022)

Editorial: Pharmacometabolomics: biomarker discovery, precision medicine, technical advances, perspectives and future applications in respiratory diseases
por: Vignoli, Alessia, et al.
Publicado: (2023)

Comprehensive clinical assays for molecular diagnostics of gliomas: the current state and future prospects
por: Penkova, Alina, et al.
Publicado: (2023)

Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives
por: Vivekanandhan, Karthik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_plk5qkmajn7vph2cd56fqrsdie